Loading company
Zymeworks Inc.
ZYME · Nasdaq · ·
Next earnings: November 5, 2026
$27.14+0.1%Sep 29 close
- 1M
- -4.0%
- 6M
- +12.1%
- 1Y
- +58.9%
- 5Y
- -8.3%
ZYME · Nasdaq · ·
Next earnings: November 5, 2026
$27.14+0.1%Sep 29 close
Zymeworks Inc. is scheduled to report next on November 5, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $4.6M | $48.7M | -90.58% |
| Profit | -$45M | $2.3M | -2,042.99% |
| Profit per share | -$0.62 | $0.03 | -2,166.67% |
| Free Cash Flow | -$31.9M | $11.6M | -376.39% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“The first half of 2026 has been a transformative period for Zymeworks, demonstrating the continued evolution of our business into a diversified, revenue-generating biotechnology business. While scientific innovation remains our foundation, we believe long-term value is created not only through discovering new medicines, but also through disciplined capital allocation, creative business development and thoughtful partnership structures that maximize the impact of that innovation for patients and shareholders,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
The quote and the company description come from Zymeworks Inc.’s Item 2.02 8-K filed August 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Zymeworks Inc. has no earnings call transcript available.